
Sonnet BioTherapeutics Holdings Inc (SONN)
NASDAQ
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -21.684 | -23.253 | -58.178 | -331.945 | -135.092 | -170.698 | -334.541 | -181.39 |
Return on Equity (%) | -55.569 | -70.627 | -698.883 | 99400 | -197.658 | -301.425 | 1362.242 | 2089.045 |
Return on Invested Capital (%) | -20.723 | -29.64 | -218.309 | 5240.043 | -198.152 | -302.621 | 1124.656 | 1406.409 |
Operating Margin (%) | -12.591 | -13.229 | -55.386 | N/A | -5161.983 | -8492 | -12725 | -39142.105 |
Net Profit Margin (%) | -16.661 | -17.169 | -59.181 | N/A | -5161.983 | -8492 | -12725 | -39142.105 |
Book Value Per Share | -2.316 | -2.193 | -1.478 | 0.205 | 0.369 | -0.458 | -0.006 | -0.093 |
Earnings Per Share | -2.266 | -1.877 | -1.715 | -4.456 | -0.415 | -5.36 | -0.489 | -1.429 |
Cash Per Share | 0.09 | 0.17 | 0.048 | 0.499 | 0.458 | 0.551 | 0.059 | 0.029 |
Working Capital Per Share | -4.303 | -3.402 | -1.627 | 0.198 | 0.367 | -0.496 | -0.02 | -0.21 |
Operating Profit Per Share | 9.107 | 7.356 | 2.021 | N/A | 0.008 | 0.063 | 0.004 | 0.004 |
EBIT Per Share | -2.564 | -2.127 | -1.669 | -1.648 | -0.415 | -5.36 | -0.489 | -1.429 |
EBITDA Per Share | -2.564 | -2.127 | -1.669 | -1.648 | -0.415 | -5.36 | -0.489 | -1.429 |
Free Cash Flow Per Share | -2.482 | -1.815 | -1.882 | -4.451 | -0.415 | -5.201 | -0.478 | -1.43 |
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 3,05M | 3,72M | 10,4M | 14,72M | 60,25M | 5,55M | N/A | N/A |
Fin d'année 30 Septembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -6152.632 | N/A | N/A | N/A | -300.2 |
Net Profit Margin (%) | N/A | N/A | N/A | -6152.632 | N/A | N/A | N/A | -316.1 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 4,26M |
Ratio cours/bénéfice | -0,57 |
Ratio prix/ventes | 224,19 |
Ratio prix/liquidités | 28,6 |
Ratio prix/valeur comptable | -8,77 |
Rendement de dividende | - |
Actions en circulation | 3,07M |
Volume moyen (1 semaine) | 19,74k |
Volume moyen (1 mois) | 60,63k |
Variation sur 52 semaines | -92,29% |
Plus haut sur 52 semaines | 18,6184 |
Plus bas sur 52 semaines | 1,30 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales